| Primary |
| Blood Testosterone Decreased |
31.0% |
| Hormone Replacement Therapy |
13.3% |
| Hypertension |
7.3% |
| Hypogonadism |
7.3% |
| Blood Pressure Abnormal |
5.0% |
| Diabetes Mellitus |
4.7% |
| Depression |
4.3% |
| Androgen Deficiency |
4.0% |
| Off Label Use |
3.3% |
| Anxiety |
3.0% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Pain |
2.3% |
| Thyroid Disorder |
2.3% |
| Blood Cholesterol Increased |
1.7% |
| Olfacto Genital Dysplasia |
1.7% |
| Diabetes Insipidus |
1.3% |
| Hiv Infection |
1.3% |
| Hypothyroidism |
1.3% |
| Testosterone Low |
1.3% |
| Asthenia |
1.0% |
|
| Drug Ineffective |
22.7% |
| Burning Sensation |
11.6% |
| Poor Quality Drug Administered |
9.9% |
| Injection Site Pain |
9.4% |
| Blood Testosterone Decreased |
4.4% |
| Product Quality Issue |
4.4% |
| Blood Testosterone Abnormal |
3.9% |
| Osteoporosis |
3.9% |
| Injection Site Swelling |
3.3% |
| Malaise |
3.3% |
| Pain |
3.3% |
| Product Deposit |
3.3% |
| Acne |
2.2% |
| Hypersensitivity |
2.2% |
| Product Contamination |
2.2% |
| Pyrexia |
2.2% |
| Weight Decreased |
2.2% |
| Weight Increased |
2.2% |
| Alopecia |
1.7% |
| Drug Effect Decreased |
1.7% |
|
| Secondary |
| Blood Testosterone Decreased |
27.2% |
| Off Label Use |
9.6% |
| Hypertension |
8.8% |
| Hypogonadism |
5.9% |
| Depression |
5.1% |
| Asthenia |
4.4% |
| Blood Pressure Abnormal |
4.4% |
| Hormone Replacement Therapy |
4.4% |
| Penis Disorder |
4.4% |
| Androgen Deficiency |
2.9% |
| Diabetes Mellitus |
2.9% |
| Testis Cancer |
2.9% |
| Anxiety |
2.2% |
| Erectile Dysfunction |
2.2% |
| Hiv Infection |
2.2% |
| Migraine |
2.2% |
| Pain |
2.2% |
| Systemic Lupus Erythematosus |
2.2% |
| Testosterone Low |
2.2% |
| Asthma |
1.5% |
|
| Drug Ineffective |
22.2% |
| Insomnia |
7.4% |
| Acne |
5.6% |
| Alopecia |
5.6% |
| Malaise |
5.6% |
| Product Quality Issue |
5.6% |
| Weight Decreased |
5.6% |
| Arthropod Sting |
3.7% |
| Blood Testosterone Abnormal |
3.7% |
| Dysphonia |
3.7% |
| Injection Site Swelling |
3.7% |
| Oedema |
3.7% |
| Poor Quality Drug Administered |
3.7% |
| Priapism |
3.7% |
| Radiculitis Brachial |
3.7% |
| Rash |
3.7% |
| Trigger Finger |
3.7% |
| Abscess |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Blood Pressure Increased |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.3% |
| Multiple Myeloma |
7.8% |
| Hiv Infection |
7.5% |
| Depression |
6.8% |
| Pain |
5.3% |
| Hypertension |
5.0% |
| Drug Use For Unknown Indication |
4.6% |
| Gastrooesophageal Reflux Disease |
3.7% |
| Restless Legs Syndrome |
3.7% |
| Blood Testosterone Decreased |
2.7% |
| Diabetes Mellitus |
2.7% |
| Nausea |
2.3% |
| Erectile Dysfunction |
2.1% |
| Hepatitis C |
2.1% |
| Blood Cholesterol Increased |
1.8% |
| Crohn's Disease |
1.8% |
| Insomnia |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Anxiety |
1.6% |
| Arthralgia |
1.6% |
|
| Weight Decreased |
20.8% |
| Blood Potassium Decreased |
6.9% |
| Osteoarthritis |
6.9% |
| Suicidal Ideation |
6.9% |
| Wheezing |
6.9% |
| Death |
5.6% |
| Drug Ineffective |
5.6% |
| Dermatitis Bullous |
4.2% |
| Feeling Abnormal |
4.2% |
| Visual Acuity Reduced |
4.2% |
| Arthralgia |
2.8% |
| Dizziness |
2.8% |
| Erectile Dysfunction |
2.8% |
| Fatigue |
2.8% |
| High Density Lipoprotein Decreased |
2.8% |
| Hydrocephalus |
2.8% |
| Insomnia |
2.8% |
| Neuropathy Peripheral |
2.8% |
| Osteonecrosis |
2.8% |
| Periodontal Disease |
2.8% |
|
| Interacting |
| Hormone Replacement Therapy |
33.3% |
| Nocturia |
33.3% |
| Prostatic Disorder |
33.3% |
|
|
